Low-Calorie Diet and Exercise Induce Type 2 Diabetes Remission

Trial Results on Early-Onset Type 2 Diabetes Remission

A randomized trial published in The Lancet Regional Health Americas found that 54 percent of adults under age 45 achieved type 2 diabetes remission within 24 weeks through a combined diet and exercise intervention. In comparison, 4 percent of participants assigned to standard medical care reached remission over the same period.

The study evaluated early-onset type 2 diabetes (EOT2D), a form of the condition diagnosed before age 45. Early-onset cases often carry a faster decline in blood sugar control and a higher rate of vascular complications compared to diagnoses later in life.

Structure of the Diet and Physical Activity Protocol

The intervention combined caloric restriction with structured aerobic and resistance training across three sites in Canada and the United Kingdom. Researchers enrolled adults aged 18 to 45 with obesity and type 2 diabetes who were not taking insulin.

Participants followed a two-phase protocol designed to test whether physical training adds measurable value to dietary restriction alone.

• Weeks 1 to 12: A daily intake of 800 to 900 calories consisting of 30 percent protein, 50 percent carbohydrate, and 20 percent fat, paired with two supervised exercise sessions and one independent workout each week.
• Weeks 13 to 24: A transition to a weight maintenance diet accompanied by independent physical activity.
• Medication management: Under medical supervision, participants discontinued glucose-lowering and blood pressure drugs at enrollment, provided they had no baseline albuminuria.

Diagnostic Criteria for Clinical Remission

Researchers defined remission as a Hemoglobin A1c (HbA1c) level below 6.5 percent, or 48 mmol/mol, maintained without glucose-lowering medication for at least 12 weeks. The trial assessed the primary outcome through blinded laboratory evaluation.

The researchers applied an intention-to-treat analysis that treated any participant with missing follow-up data as not having achieved remission. This standard prevented loss to follow-up from inflating the observed success rate.

Considerations for Clinical Practice and Long-Term Durability

Type 2 diabetes remission does not equal a permanent cure. Blood glucose levels can rise back into the diabetes range if weight returns or beta-cell function declines further.

Individuals interested in caloric restriction or drug deprescribing should consult their personal physician before making changes. Discontinuing prescribed medications requires close clinical oversight to monitor for rebound hyperglycemia or kidney strain.